Organovo Holdings, Inc. (NASDAQ:ONVO) – Jefferies Group reduced their Q3 2018 earnings estimates for shares of Organovo Holdings in a research report issued to clients and investors on Thursday. Jefferies Group analyst B. Couillard now expects that the company will post earnings of ($0.10) per share for the quarter, down from their previous forecast of ($0.09). Jefferies Group has a “Buy” rating and a $4.00 price objective on the stock. Jefferies Group also issued estimates for Organovo Holdings’ Q2 2019 earnings at ($0.09) EPS, Q3 2019 earnings at ($0.07) EPS, Q4 2019 earnings at ($0.07) EPS and FY2019 earnings at ($0.32) EPS.

Organovo Holdings (NASDAQ:ONVO) last issued its quarterly earnings results on Wednesday, August 9th. The company reported ($0.10) EPS for the quarter, hitting analysts’ consensus estimates of ($0.10). The business had revenue of $0.99 million during the quarter, compared to the consensus estimate of $0.92 million. Organovo Holdings had a negative net margin of 918.97% and a negative return on equity of 65.49%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. COPYRIGHT VIOLATION WARNING: “Q3 2018 EPS Estimates for Organovo Holdings, Inc. (ONVO) Lowered by Jefferies Group” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/11/q3-2018-eps-estimates-for-organovo-holdings-inc-onvo-lowered-by-jefferies-group.html.

ONVO has been the topic of a number of other reports. ValuEngine lowered Organovo Holdings from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st. BidaskClub lowered Organovo Holdings from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 25th. Finally, Zacks Investment Research raised Organovo Holdings from a “hold” rating to a “buy” rating and set a $2.25 target price on the stock in a report on Wednesday. Two research analysts have rated the stock with a sell rating and five have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $6.00.

Shares of Organovo Holdings (NASDAQ:ONVO) traded up 0.59% during midday trading on Monday, hitting $1.71. 2,906,091 shares of the stock were exchanged. Organovo Holdings has a one year low of $1.69 and a one year high of $4.08. The stock’s 50-day moving average price is $2.07 and its 200 day moving average price is $2.51. The stock’s market cap is $181.47 million.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Cambridge Investment Research Advisors Inc. grew its holdings in Organovo Holdings by 1.0% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 91,204 shares of the company’s stock valued at $240,000 after buying an additional 890 shares in the last quarter. Schwab Charles Investment Management Inc. grew its holdings in Organovo Holdings by 0.7% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 388,300 shares of the company’s stock valued at $1,022,000 after buying an additional 2,641 shares in the last quarter. American International Group Inc. grew its holdings in Organovo Holdings by 7.9% in the 1st quarter. American International Group Inc. now owns 53,431 shares of the company’s stock valued at $170,000 after buying an additional 3,920 shares in the last quarter. Rhumbline Advisers grew its holdings in Organovo Holdings by 4.4% in the 2nd quarter. Rhumbline Advisers now owns 110,444 shares of the company’s stock valued at $290,000 after buying an additional 4,640 shares in the last quarter. Finally, Nationwide Fund Advisors grew its holdings in Organovo Holdings by 12.7% in the 1st quarter. Nationwide Fund Advisors now owns 60,565 shares of the company’s stock valued at $193,000 after buying an additional 6,802 shares in the last quarter. 23.94% of the stock is currently owned by hedge funds and other institutional investors.

About Organovo Holdings

Receive News & Stock Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related stocks with our FREE daily email newsletter.